Found 96 Enz. Inhib. hit(s) with Target = 'Solute carrier family 2, facilitated glucose transporter member 3'
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 64nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 68nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 69nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 96nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 121nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 138nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 155nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 175nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 179nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 211nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 232nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 275nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 287nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 298nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 325nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 340nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibition of human GLUT3 expressed in GLUT1 knock-out DLD1 cells assessed as ATP production co-incubated with 300 mM glucose for 16 hrs by CellTiter...More data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Bayer Pharma
Curated by ChEMBL
Bayer Pharma
Curated by ChEMBL
Affinity DataIC50: 365nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair